<DOC>
	<DOCNO>NCT01235923</DOCNO>
	<brief_summary>Preterm infant risk multiple transfusion , administration human recombinant erythropoietin ( Epo ) show decrease transfusion requirement . Dosing usually occur three time week , extend dosing schedule successful adult . The investigator assess weekly Epo dose preterm infant compare standard three time weekly dosing .</brief_summary>
	<brief_title>Randomized Study Weekly Erythropoietin Dosing Preterm Infants</brief_title>
	<detailed_description>Erythropoietin ( Epo ) increase maintains hematocrit use weekly dosing adult anemia due end stage renal disease . Epo use preterm infant treat anemia prematurity , study use weekly dosing . We compare reticulocyte response weekly Epo dose thrice weekly dose preterm infant . Infants ≤1,500 gram ≥7 day age randomize weekly Epo , 1,200 units/kg/dose , thrice weekly Epo , 400 units/kg/dose , subcutaneously 4 week , along iron vitamin supplementation . Complete blood count , absolute reticulocyte count ( ARC ) , transfusion , phlebotomy loss , adverse event record .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>&lt; = 1,500 gram &lt; = 32 week gestation &gt; = 7 day age inform consent obtain hemolytic disease hypertension seizures thrombose major malformation</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>100 Days</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>anemia</keyword>
	<keyword>transfusion</keyword>
	<keyword>erythropoiesis</keyword>
	<keyword>neonate</keyword>
	<keyword>preterm</keyword>
</DOC>